AFP and hepatocellular carcinoma: Furthermore, an increase in serum AFP level (20-200 ng/ml) is identified in a significant percentage of patients with chronic liver disease, including 5-58% of patients with chronic hepatitis, and 11-47% of patients with cirrhosis. Of note, even some histologically proven HCC tumors are regarded as AFP-negative HCCs.